These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 19220601)

  • 21. Summary of the practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults.
    Greenhill LL; Pliszka S; Dulcan MK; Bernet W; Arnold V; Beitchman J; Benson RS; Bukstein O; Kinlan J; McClellan J; Rue D; Shaw JA; Stock S; Kroeger K
    J Am Acad Child Adolesc Psychiatry; 2001 Nov; 40(11):1352-5. PubMed ID: 11699811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are stimulants overprescribed for youths with ADHD?
    Safer DJ
    Ann Clin Psychiatry; 2000 Mar; 12(1):55-62. PubMed ID: 10798827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adverse effects of stimulant medications in children and adolescents: focus on drug abuse.
    Greydanus DE; Cates KW; Sadigh N
    Int J Adolesc Med Health; 2019 Sep; 31(4):. PubMed ID: 31483757
    [No Abstract]   [Full Text] [Related]  

  • 24. Commentary on Levy (2012) politics vs practice: withdrawal of the draft NHMRC ADHD guidelines.
    Starling J
    Aust N Z J Psychiatry; 2013 Jan; 47(1):91-2. PubMed ID: 23293314
    [No Abstract]   [Full Text] [Related]  

  • 25. CNS stimulant controversies.
    Levy F
    Aust N Z J Psychiatry; 1989 Dec; 23(4):497-502. PubMed ID: 2575372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sudden Increases in U.S. Stimulant Prescribing: Alarming or Not?
    Sibley MH; Faraone SV; Nigg JT; Surman CBH
    J Atten Disord; 2023 Apr; 27(6):571-574. PubMed ID: 36946184
    [No Abstract]   [Full Text] [Related]  

  • 27. Psychotherapeutic medication patterns for youths with attention-deficit/hyperactivity disorder.
    Zito JM; Safer DJ; dosReis S; Magder LS; Gardner JF; Zarin DA
    Arch Pediatr Adolesc Med; 1999 Dec; 153(12):1257-63. PubMed ID: 10591302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of growth hormone for non-growth hormone deficient children.
    Diller L
    JAMA; 1996 Dec; 276(23):1877-8; author reply 1878. PubMed ID: 8968011
    [No Abstract]   [Full Text] [Related]  

  • 29. ADHD in Western Australia: an iatrogenic 'epidemic' cured by bureaucracy? Time to focus on the facts.
    Paterson R
    Aust N Z J Psychiatry; 2013 Jan; 47(1):88-9. PubMed ID: 23293312
    [No Abstract]   [Full Text] [Related]  

  • 30. Getting to Long-Term Effectiveness and Safety of Attention-deficit Hyperactivity Disorder Medications.
    Beau-Lejdstrom R; Zito JM
    Clin Pharmacol Ther; 2018 Oct; 104(4):610-612. PubMed ID: 30120774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medication management of stimulants in pediatric practice settings: a national perspective.
    Hoagwood K; Jensen PS; Feil M; Vitiello B; Bhatara VS
    J Dev Behav Pediatr; 2000 Oct; 21(5):322-31. PubMed ID: 11064959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of ADHD with stimulant medications: response to Nissen perspective in the New England Journal of Medicine.
    Biederman J; Spencer TJ; Wilens TE; Prince JB; Faraone SV
    J Am Acad Child Adolesc Psychiatry; 2006 Oct; 45(10):1147-1150. PubMed ID: 16840880
    [No Abstract]   [Full Text] [Related]  

  • 33. Dopamine receptors and the pharmacogenetics of side-effects of stimulant treatment for attention-deficit/hyperactivity disorder.
    Levy F; Wimalaweera S; Moul C; Brennan J; Dadds MR
    J Child Adolesc Psychopharmacol; 2013 Aug; 23(6):423-5. PubMed ID: 23952191
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacotherapy in ADHD. Guidelines for prescribing stimulant medications in young children.
    August GJ; Realmuto GM
    Minn Med; 2000 Jun; 83(6):45-6. PubMed ID: 10881573
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacotherapy for incident attention-deficit/hyperactivity disorder: practice patterns and quality metrics.
    Bussing R; Narwaney KJ; Winterstein AG; Newton DA; DeBar L; Boscarino JA; Toh S; Pawloski P; Nordin JD; Herrinton LJ; Mason D; Daley MF
    Curr Med Res Opin; 2014 Aug; 30(8):1687-99. PubMed ID: 24635013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attitudes Toward Stimulant Treatment of Offspring of Adult Patients with Attention-Deficit/Hyperactivity Disorder.
    Canela C; Buadze A; Dube A; Eich D; Liebrenz M
    J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):422-428. PubMed ID: 28422527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated treatment of aggression in the context of ADHD in children refractory to stimulant monotherapy: a window into the future of child psychopharmacology.
    Steiner H; Karnik NS
    Am J Psychiatry; 2009 Dec; 166(12):1315-7. PubMed ID: 19952080
    [No Abstract]   [Full Text] [Related]  

  • 38. Attention Deficit Hyperactivity Disorder in Athletes.
    Ciocca M
    Clin Sports Med; 2019 Oct; 38(4):545-554. PubMed ID: 31472765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of family structure on stimulant use among children with attention-deficit/hyperactivity disorder.
    Rabbani A; Alexander GC
    Health Serv Res; 2009 Dec; 44(6):2060-78. PubMed ID: 19732168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term safety of stimulant medications used to treat children with ADHD.
    Lerner M; Wigal T
    Pediatr Ann; 2008 Jan; 37(1):37-45. PubMed ID: 18240852
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.